Related Experiment Video
Updated: Aug 10, 2025

08:36
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
645
CD8 Encephalitis in HIV: A Review of This Emerging Entity
Aniruddh Shenoy1, Pavan Kaur Marwaha2, Dominic Adam Worku3,4
1Haematology, Christie Hospital, Manchester M20 4BX, UK.
Journal of Clinical Medicine
|February 11, 2023
Summary
CD8 Encephalitis (CD8E) is a rare HIV-associated neurological condition. Corticosteroids show a survival benefit, but further research is needed for risk factors and diagnosis.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Encephalitis in Human Immunodeficiency Virus (HIV) patients presents diverse etiologies.
- CD8 Encephalitis (CD8E) is a recently identified condition characterized by CD8+ T cell infiltration in the brain.
- This review aims to elucidate CD8E's symptoms, distribution, determinants, and knowledge gaps.
Purpose of the Study:
- To review and synthesize current knowledge on CD8 Encephalitis (CD8E).
- To clarify the clinical presentation, radiological findings, and diagnostic challenges of CD8E.
- To evaluate treatment outcomes and identify potential risk factors and prognostic indicators.
Main Methods:
- A comprehensive literature review was conducted using PubMed and Google Scholar databases.
- Papers published between 2006 and 2022 were analyzed, focusing on 57 identified patient cases.
- Statistical analyses included Chi-squared and Wilcoxon rank-sum tests to assess significance.
Main Results:
- The review identified a female and Black African predominance in CD8E cases.
- Headache was a common symptom, particularly in females and associated with mortality.
- Corticosteroid treatment demonstrated a significant mortality benefit (71% survival), though brain biopsy was often required for diagnosis.
Conclusions:
- CD8E is a complex, likely underdiagnosed condition with limited identified risk factors.
- Headache is a key symptom associated with poorer outcomes in females.
- Corticosteroids improve survival, but optimal treatment strategies and non-invasive diagnostic biomarkers require further investigation.

